Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 2Inflammation 2Uveal Melanoma 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Eye Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cachexia 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Pleurodesis 4Cisplatin 3Chest Tubes 3Bevacizumab 3Silver Nitrate 2Povidone-Iodine 2camrelizumab 1Thoracoscopy 1Thiostrepton 1Sodium Chloride 1Saline Solution 1Radiation 1One-Lung Ventilation 1Morphine 1Magnetic Resonance Spectroscopy 1Lidocaine 1Immunotherapy, Adoptive 1Ibuprofen 1Genes, fms 1Fentanyl 1Drug Therapy 1Doxycycline 1Anesthesia, Local 1Anesthesia, General 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pleural Effusion, Malignant × Ibuprofen × Clear all
NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡